{
  "id": 11199547,
  "title": "Gut mRNA tech supercharges vaccine and GLP-1 delivery",
  "url": "https://urgent.news/2026/10/01/gut-mrna-tech-supercharges-vaccine-and-glp-1-delivery",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-01T13:00:02.000Z",
  "source": {
    "name": "Phys.org",
    "slug": "phys-org",
    "url": "https://phys.org/news/2026-10-gut-mrna-tech-supercharges-vaccine.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "From vaccines to gene therapies, mRNA medicines often rely on tiny fat-based particles called lipid nanoparticles, or LNPs, to carry treatments where they need to go. But researchers still face a fundamental challenge: getting those therapies to the organs where they are needed most while limiting side effects elsewhere in the body.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}